Catherine C. Turkel, President at Novus Therapeutics, Inc. (NVUS), sold 9,537 shares at $1.91 ($19K) on 2019-05-21, disclosed to the SEC on 2019-05-22.
Open-market sale of $19k NVUS by President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.96 | 7,623 | $15K | 80.3% |
| 2 | $1.91 | 1,914 | $4K | 19.7% |
| Total | $1.95 avg | 9,537 | $19K | 100% |
| Filing → |
| NVUS | BUY | 2018-09-13 | $322K | — | Filing → |
| NVUS | BUY | 2018-09-07 | $3K | — | Filing → |
| NVUS | BUY | 2017-05-11 | $222K | — | Filing → |